. 2020 Oct 6;7(2):370–377. doi: 10.1002/vms3.369

TABLE 4.

Mean ± SE fatty acid composition of RBC membranes (%) across the study period by supplement type (Astaxanthin krill oil, AKO and flaxseed oil, FSO)

Fatty acid (%)		Diet	0 weeks	3 weeks	6 weeks
∑Trans		AKO	0.47 ± 0.01	0.48 ± 0.01	0.36 ± 0.01
		FSO	0.46 ± 0.00	0.48 ± 0.01	0.37 ± 0.01
∑Saturated		AKO	43.40 ± 0.15	43.52 ± 0.22	46.03 ± 0.05
		FSO	43.08 ± 0.25	43.62 ± 0.30	46.57 ± 0.22
∑Monounsaturated		AKO	12.34 ± 0.14	11.86 ± 0.12	10.97 ± 0.12
		FSO	12.59 ± 0.17	12.05 ± 0.14	10.99 ± 0.12
Polyunsaturated	18:3 n−3 (ALA)	AKO	0.28 ± 0.02	0.24 ± 0.01^a	0.18 ± 0.01^a
		FSO	0.30 ± 0.02	0.37 ± 0.01^b	0.27 ± 0.01^b
	20:5 n−3 (EPA)	AKO*	0.69 ± 0.03^a	1.67 ± 0.07^a	1.52 ± 0.06^a
		FSO	0.65 ± 0.03^a	0.53 ± 0.02^b	0.43 ± 0.02^b
	22:5 n−3 (DPA)	AKO*	0.65 ± 0.04^a	1.02 ± 0.08^a	0.98 ± 0.07^a
		FSO	0.64 ± 0.04^a	0.74 ± 0.07^b	0.67 ± 0.05^b
	22:6 n−3 (DHA)	AKO*	0.99 ± 0.04^a	1.16 ± 0.05^a	1.18 ± 0.05^a
		FSO	0.95 ± 0.06^a	0.65 ± 0.04^b	0.54 ± 0.04^b
	18:2 n−6 (Linoleic)	AKO	17.02 ± 0.47	15.93 ± 0.46	14.08 ± 0.22
		FSO	16.98 ± 0.93	16.22 ± 0.34	14.29 ± 0.25
	20:4 n−6 (Arachidonic)	AKO	20.99 ± 0.47	21.05 ± 0.41	21.42 ± 0.33
		FSO	21.21 ± 0.82	21.95 ± 0.41	22.33 ± 0.34
∑n−3		AKO*	2.60 ± 0.06^a	4.09 ± 0.16^a	3.86 ± 0.13^a
		FSO	2.54 ± 0.10^a	2.28 ± 0.11^b	1.90 ± 0.10^b
∑n−6		AKO	41.19 ± 0.24^a	40.05 ± 0.12^a	38.78 ± 0.18^a
		FSO	41.34 ± 0.19^a	41.57 ± 0.22^b	40.19 ± 0.23^b

Abbreviations: ALA, α‐linolenic acid, AKO, astaxanthin krill oil, DHA: docosahexaenoic acid, DPA: docosapentaenoic acid, EPA: eicosapentaenoic acid, FSO: flaxseed oil.

Denotes a significant difference in within‐group (row‐wise) values from week 0 to 6 at p < .05. Besides, different superscript symbols (a, b) denote a significant difference between groups (column‐wise) values at p < .05.